Examination for the role of humoral factors in patients with Brugada Syndrome

Examination for the role of humoral factors in patients with Brugada Syndrome - Examination for the role of humoral factors in patients with Brugada Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023121

Enrollment

Registered

2016-10-01

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brugada Syndrome

Interventions

Patients arm

Blood sampling and electrocardiogram of patients with Brugada syndrome is examined after intake of a certain amount of meal. Examinations are done before intake of meal and after 1 hour, 2 hour and 3

Blood sampling and electrocardiogram of patients with healthy controls examined after intake of a certain amount of meal. Examinations are done before intake of meal and after 1 hour, 2 hour and 3 hou

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Brugada syndrome definitely diagnosed according to guideline of Japanese Circulation Society, and healthy controls, who have no particular past history and have similar age and gender with patients with Brugada syndrome.

Exclusion criteria

Exclusion criteria: Febrile patients, and patients with intake of Tacrolimus.

Design outcomes

Primary

Measure	Time frame
Changes of humoral factors and associated electrocardiogram changes	—

Secondary

Measure	Time frame
Laboratory data; Inflammatory marker, such as White Blood Cells, CRP, Inflammatory cytokines, Serum lipid Electrocardiogram change	—

Countries

Japan

Contacts

Public ContactMakoto Nakano

Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine

vdm@cardio.med.tohoku.ac.jp0227177153

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026